Why CytoDyn Inc.’s leronlimab data could reshape TNBC immunotherapy strategies
Discover how CytoDyn Inc.’s leronlimab data could reshape TNBC immunotherapy and expand checkpoint treatment potential.
Pharma & Biotech
Medical Devices & Diagnostics
How Creatv Bio’s LifeTracDx may change immune biomarker tracking in colorectal cancer studies
Creatv Bio’s LifeTracDx joins CytoDyn’s Phase 2 colorectal cancer trial as a liquid biopsy biomarker tool. Discover what this means for oncology diagnostics.